January 2026 | Source: Pharmexcil
━━━━━━━━━━━━━━━━━━━━━━━
OVERVIEW
India's pharmaceutical exports crossed USD 30 billion in 2025 including formulations, APIs and
vaccines. Pharmexcil outlines 2026 strategy focused on quality leadership, regulatory compliance and
new market diversification.
━━━━━━━━━━━━━━━━━━━━━━━━
KEY HIGHLIGHTS
- Pharma exports FY25: USD 30 billion+
- Products covered:
- Bulk drugs (APIs)
- Formulations (tablets, capsules)
- Biotech products
- Vaccines
- Indian systems of medicines
- Herbal products
- India = 3rd largest pharma producer globally
- India = pharmacy of the world
- 2026 focus: Quality + Compliance
- New markets being explored
━━━━━━━━━━━━━━━━━━━━━━━━
PHARMEXCIL 2026 STRATEGY
📌PILLAR 1 — QUALITY LEADERSHIP:
Moving beyond volume-led growth.
Focus on value-driven high-quality manufacturing. Pharmexcil Chairman
Namit Joshi emphasises consistent quality as key to export competitiveness.
📌 PILLAR 2 — MARKET DIVERSIFICATION:
Reducing dependence on limited markets.
Expanding into:
- Africa (growing pharma demand)
- Southeast Asia (ASEAN markets)
- Latin America (Brazil, Mexico)
- Central Asia (Uzbekistan, Kazakhstan)
- CIS countries
📌 PILLAR 3 — PRODUCT UPGRADATION:
Shift from conventional generics to:
- Complex formulations
- Biosimilars
- Specialty APIs
- High-value products
━━━━━━━━━━━━━━━━━━━━━━━━
RECENT PHARMEXCIL ACTIVITIES
International Business Meets:
- India-Uzbekistan Pharma Business Meet
- India-Cambodia Pharma Business Meet
- Injectable Innovations Conclave 2026
- India Pavilion at WHX 2026 (formerly Arab Health) — inaugurated by Indian Ambassador
Capacity Building:
GMP Compliance workshops for pharma MSMEs conducted across India.
━━━━━━━━━━━━━━━━━━━━━━━━
WHO BENEFITS FROM THIS
BULK DRUG MANUFACTURERS (APIs):
India produces 20% of world generic medicines. Growing global demand for Indian APIs especially
post-COVID.Hyderabad, Ahmedabad, Baddi are major API manufacturing hubs.
FORMULATION COMPANIES (Hyderabad, Mumbai, Ahmedabad):
World's largest generic medicine suppliers. USA, Europe, Africa are top export destinations.
HERBAL & AYURVEDIC EXPORTERS:
Growing global interest in Indian traditional medicine systems.AYUSH exports growing rapidly.
BIOTECH & VACCINE MAKERS:
India supplies 60% of world vaccines.Serum Institute, Bharat Biotech leading global vaccine exports.
━━━━━━━━━━━━━━━━━━━━━━━━
INDIA PHARMA EXPORT FACTS
- Total exports: USD 30 billion+
- Export destinations: 200+ countries
- Generic market share: 20% globally
- Vaccine supply: 60% of world
- Manufacturing units: 3,000+
- WHO-GMP certified facilities
- Employment: 3 million+ workers
━━━━━━━━━━━━━━━━━━━━━━━━
WHAT PHARMA EXPORTERS SHOULD DO
✅ Register with Pharmexcil
Website: pharmexcil.com
✅ Get WHO-GMP certification
✅ Explore new markets via Pharmexcil business meets
✅ Upgrade to complex formulations
✅ Comply with destination country regulatory requirements
✅ Apply for MAI/MDA scheme funds for market development
━━━━━━━━━━━━━━━━━━━━━━━━
SOURCE:
Pharmexcil | pharmexcil.com
Industrial Talks | January 2026